Hypophosphatemia in juvenile patients with systemic lupus erythematosus.
BACKGROUND
Hypophosphatemia is observed in both genetic diseases and acquired disorders, although it has never been described in systemic lupus erythematosus (SLE). The present study reports hypophosphatemia observed in patients with SLE, and investigates whether serum phosphorus (P) concentration is associated with disease activity and some cytokines.


METHODS
Six girls with SLE (age 10 to 16 years) and seven age-matched controls were studied. Relationships between serum P and parameters that represented disease activity were evaluated. Interleukin (IL) 6 and tumor necrosis factor alpha (TNF-alpha) levels were measured by enzyme-linked immunosorbent assay (ELISA).


RESULTS
Two of the patients with SLE developed marked hypophosphatemia during active disease. Their serum P significantly correlated positively with serum complements, red blood cell (RBC) and platelet counts, and negatively with anti-double-stranded DNA antibody (dsDNAab). Three of the remaining four patients showed the same trend, in which their serum P significantly correlated with RBC, platelets, dsDNAab and/or serum complement concentrations. Serum and urinary IL-6 and serum TNF-alpha were higher in active SLE patients than those with inactive disease or in the control group. In addition, the concentrations of these cytokines significantly correlated inversely with serum P. Renal tubular reabsorption of P was significantly lower in patients with active disease both with and without lupus nephritis.


CONCLUSIONS
Hypophosphatemia may be another sign of juvenile SLE, and serum P may represent disease activity. Both TNF-alpha and IL-6 may be related to hypophosphatemia in patients with SLE. Waste of P from renal tubules may be a possible mechanism of hypophosphatemia in SLE.
Fujiwara
Ikuma
I
Department of Pediatrics, Tohoku University School of Medicine, Sendai, Japan. ifujiwara@ped.med.tohoku.ac.jp
Ogawa
Eishin
E
Kondo
Yoshiaki
Y
Ohura
Toshihiro
T
Iinuma
Kazuie
K
D000293:Adolescent; D002648:Child; D005260:Female; D006801:Humans; D017674:Hypophosphatemia / Q000097:blood / Q000150:complications*; D015850:Interleukin-6 / Q000097:blood; D008180:Lupus Erythematosus, Systemic / Q000097:blood / Q000150:complications*; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis
D015850:Interleukin-6; D014409:Tumor Necrosis Factor-alpha